Advertisement
MCP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     



This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Glossary
Google Scholar
Right arrow Articles by Cockman, M. E.
Right arrow Articles by Ratcliffe, P. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cockman, M. E.
Right arrow Articles by Ratcliffe, P. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted on July 24, 2008
Revised on October 3, 2008
Accepted on October 20, 2008

Proteomic-based identification of novel factor inhibiting HIF (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteins

Matthew E. Cockman, James D. Webb, Holger B. Kramer, Benedikt M. Kessler, and Peter J. Ratcliffe

Clinical Medicine, University of Oxford, Oxford, Oxon OX3 7BN

Corresponding Author: bmk{at}ccmp.ox.ac.uk

Post-translational hydroxylation has been considered an unusual modification on intracellular proteins. However, following the recognition that oxygen sensitive prolyl and asparaginyl hydroxylation are central to the regulation of the transcription factor hypoxia inducible factor (HIF), interest has centred on the possibility that these enzymes may have other substrates in the proteome. In support of this certain ankyrin repeat domain (ARD)-containing proteins, including members of the I(kappa)B and Notch families, have been identified as alternative substrates of the HIF asparaginyl hydroxylase factor inhibiting HIF (FIH). Whilst these findings imply a potentially broad range of substrates for FIH, the precise extent of this range has been difficult to determine, due to the difficulty of capturing transient enzyme-substrate interactions. Here we describe the use of pharmacological “substrate trapping” together with stable isotope labeling of amino acids in cell culture (SILAC) technology to stabilize and identify potential FIH-substrate interactions by mass spectrometry. To pursue these potential FIH substrates we used conventional data-directed tandem MS together with alternating low/high collision energy tandem MS to assign and quantitate hydroxylation at target asparaginyl residues. Overall the work has defined thirteen new FIH-dependent hydroxylation sites with a degenerate consensus corresponding to that of the ankyrin repeat, and a range of ARD-containing proteins as actual and potential substrates for FIH. Several ARD-containing proteins were multiply hydroxylated and detailed studies of one, Tankyrase-2 revealed eight sites that were differentially sensitive to FIH-catalyzed hydroxylation. These findings indicate that asparaginyl hydroxylation is likely to be widespread among the circa 300 ARD-containing species in the human proteome.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2008 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement